Clinical Trial Update: A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer [Phase 2]

View source ↗

Summary

This is a single-arm Phase 2 trial of oxaliplatin and 5-fluorouracil with concurrent radiation for metastatic rectal cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED